Australia markets closed

Infinity Pharmaceuticals, Inc. (INFI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5500+0.0600 (+4.03%)
At close: 04:00PM EDT
1.5000 -0.05 (-3.23%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 133.02M
Enterprise value 77.64M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)59.86
Price/book (mrq)8.03
Enterprise value/revenue 35.02
Enterprise value/EBITDA -1.68

Trading information

Stock price history

Beta (5Y monthly) 2.00
52-week change 3-48.68%
S&P500 52-week change 3-3.56%
52-week high 33.8900
52-week low 30.4600
50-day moving average 30.7890
200-day moving average 31.2488

Share statistics

Avg vol (3-month) 3757.99k
Avg vol (10-day) 31.32M
Shares outstanding 589.28M
Implied shares outstanding 6N/A
Float 875.88M
% held by insiders 11.25%
% held by institutions 134.90%
Shares short (28 July 2022) 41.4M
Short ratio (28 July 2022) 44.55
Short % of float (28 July 2022) 41.60%
Short % of shares outstanding (28 July 2022) 41.57%
Shares short (prior month 29 June 2022) 41.59M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 312 Sept 2006

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,105.32%

Management effectiveness

Return on assets (ttm)-35.48%
Return on equity (ttm)-231.42%

Income statement

Revenue (ttm)2.22M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)34.00%
Gross profit (ttm)-30.91M
EBITDA -46.19M
Net income avi to common (ttm)-46.79M
Diluted EPS (ttm)-0.5190
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)56.58M
Total cash per share (mrq)0.63
Total debt (mrq)1.19M
Total debt/equity (mrq)N/A
Current ratio (mrq)4.16
Book value per share (mrq)-0.01

Cash flow statement

Operating cash flow (ttm)-41.71M
Levered free cash flow (ttm)-22.54M